📍 Whitefield, Bangalore
HOD & Senior Consultant · Surgical Oncology
Consultation by Appointment
Home/Cancer Specialties/Gynecological Cancer
Cancer Specialties

Gynecological Cancer Surgery

Surgical treatment of ovarian and related gynecological cancers, including cytoreductive surgery for advanced disease.
Cytoreductive Surgery
HIPEC
Robotic Surgery
Fertility Counselling

How your treatment is personalised

Every treatment plan is personalised. Dr Ashwin K.R. reviews your scans, pathology and, where relevant, biomarker results with a multidisciplinary team, then recommends a sequence of treatment that fits your cancer and your health.

  • Your case is reviewed at a multidisciplinary tumour board.
  • Surgery, systemic treatment and radiotherapy are explained with their goals and side effects.
  • A second opinion is welcome, and you can bring your reports to the consultation.

Looking for more detail? Read our complete guide with 55 patient FAQs: Gynecological Cancer Treatment FAQs.

Overview

Gynecological Cancer Surgery is one of Dr Ashwin K.R.’s core areas of practice at Aster Whitefield, Bangalore. Treatment planning combines careful staging, multidisciplinary discussion and a surgical approach chosen to balance oncological safety with quality of life.

Symptoms & When to See a Surgeon

  • Persistent bloating or abdominal distension
  • Pelvic pain or a palpable pelvic mass
  • Abnormal vaginal bleeding or discharge
  • Early satiety or unexplained change in bowel/bladder habit
These symptoms have many possible causes, but persistent or unexplained symptoms warrant a timely surgical oncology consultation.

Surgical Treatment Approach

  • Cytoreductive surgery for ovarian and peritoneal-spread disease
  • HIPEC for selected patients with peritoneal involvement
  • Robotic and minimally invasive approaches where suitable
  • Coordinated planning with gynecological and medical oncology
Where relevant, this may draw on HIPEC & PIPAC → as part of an integrated treatment plan.

Why Choose Dr Ashwin K.R.

16+ years of experience, 11,000+ major cancer surgeries and a practice built on clear communication — every patient understands their diagnosis, options and the realistic road ahead before deciding on surgery.

Quick facts

Experience
16+ years
Hospital
Aster Whitefield
Location
Whitefield, Bangalore
Approach
Multidisciplinary

Have reports for a gynecological cancer diagnosis?

Bring your pathology and imaging reports for a focused surgical opinion.

Recovery and what to bring to your consultation

  • Recovery depends on the treatment you need. Your team will explain the expected hospital stay, return to daily activities and follow-up before any treatment starts.
  • Bring your pathology and imaging reports, any blood test results, a list of current medicines, summaries of any earlier treatment, and your ID and insurance documents.

Frequently Asked Questions

1. Understanding Your Gynecological Cancer Diagnosis

Is gynecological cancer curable?

Many gynecological cancers can be cured, particularly when they are diagnosed at an early stage and treated by a specialist gynecologic oncology team.

Your chance of cure depends on:

  • The type and subtype of cancer
  • The stage (how far it has spread)
  • The grade (how aggressive the cells look)
  • Molecular features such as BRCA, HRD or mismatch repair status
  • Your overall health and response to treatment

What the evidence shows (five-year survival, approximate):

  • Early-stage endometrial (uterine) cancer: more than 9 in 10 women; many are treated successfully with surgery alone.
  • Early-stage cervical cancer: about 9 in 10 women after surgery or chemoradiation.
  • Early-stage ovarian cancer: about 9 in 10 women, although only a minority are diagnosed this early.
  • Advanced disease: combination treatment can lead to long remissions and, for some women, cure; for others it can be controlled over time, much like a chronic illness.

What is gynecological cancer?

Gynecological cancer is any cancer that starts in a woman's reproductive organs: the ovaries, fallopian tubes, uterus, cervix, vagina or vulva.

The algorithm below shows how gynecological cancers are classified. Read it from left to right:

  • The organ where the cancer starts
  • The type of cancer
  • Its main subtypes
  • The key warning sign and main treatment

Figure 1. Algorithm of the types of gynecological cancer, their subtypes, key warning signs and main treatments

Why the exact type matters:

  • Each type behaves differently and has different causes.
  • Each type is treated differently, so an accurate diagnosis of type and subtype is the foundation of your plan.
  • Care is best led by a gynecologic oncologist, a surgeon specially trained in cancers of the female reproductive system.

What are the different types of gynecological cancer?

There are five main types of gynecological cancer: uterine (endometrial), ovarian (including fallopian tube and primary peritoneal), cervical, vulvar and vaginal cancer.

Table 1. Types of gynecological cancer at a glance

Type of CancerWhere It StartsKey Facts
Uterine / Endometrial cancerLining of the womb (endometrium); rarely the uterine muscle (sarcoma)Among the most common gynecological cancers; often found early because of abnormal bleeding
Ovarian cancerOvaries, fallopian tubes or peritoneumFrequently diagnosed at an advanced stage; many high-grade serous cancers are thought to begin in the fallopian tube
Cervical cancerCervix (neck of the womb)Nearly all cases are linked to persistent high-risk HPV infection; largely preventable with vaccination and screening
Vulvar cancerOuter genital skin (vulva)More common in older women; linked to HPV or chronic skin conditions such as lichen sclerosus
Vaginal cancerLining of the vaginaRare; often HPV-related and usually treated with radiation
Gestational trophoblastic diseasePlacental tissue after pregnancyRare; cure rates are very high, even when it has spread

What caused my cancer? Did I do something wrong?

In most cases, nothing you did caused your cancer. Gynecological cancers usually result from a combination of genetic changes, hormones, infections such as HPV and ageing, most of which are outside anyone's control.

  • Knowing risk factors can help protect your family members and guide your treatment.
  • Risk factors are not a reason for guilt or blame; many women with cancer have none of them.

Table 2. Main risk factors by cancer type

Cancer TypeMain Risk Factors
Uterine / EndometrialObesity, excess estrogen, diabetes, polycystic ovary syndrome (PCOS), never having been pregnant, late menopause, tamoxifen use, Lynch syndrome
OvarianIncreasing age, BRCA1/BRCA2 mutations, Lynch syndrome, family history, endometriosis, never having been pregnant
CervicalPersistent high-risk HPV infection, smoking, weakened immunity (e.g. HIV), lack of regular screening
Vulvar and VaginalHPV infection, smoking, lichen sclerosus, older age, weakened immunity

How quickly do I need to start treatment?

Most women begin treatment within about two to six weeks of diagnosis, a timeframe generally considered appropriate for completing staging, planning and a second opinion if wanted.

  • For most gynecological cancers, a short planning period of a few weeks is not expected to affect outcomes.
  • Taking time to get the right plan is usually better than rushing.
  • Your oncologist will tell you if your situation needs faster action.

Situations that may need urgent treatment:

  • Heavy vaginal bleeding
  • Bowel or kidney blockage
  • Rapidly accumulating abdominal fluid (ascites) or breathlessness
  • Fast-growing cancers such as some high-grade tumors

Table 3. Typical timeline from diagnosis to treatment

StepWhat HappensTypical Timeframe*
1. First specialist consultationHistory, examination, review of existing reportsWithin 1 week of referral
2. Staging testsBlood tests, MRI / CT / PET-CT, additional biopsy if needed1–2 weeks
3. Pathology reviewConfirmation of type, grade and initial biomarkers3–7 working days
4. Tumor board discussionMultidisciplinary team agrees on the treatment planWithin about 1 week of results
5. Treatment plan consultationPlan, alternatives, side effects and costs explainedShortly after tumor board
6. Treatment beginsSurgery, chemotherapy or radiationAbout 2–6 weeks from diagnosis

*Timeframes vary with your cancer, test availability and personal circumstances.

Should I get a second opinion for gynecological cancer?

A second opinion is a normal, widely accepted part of cancer care, and most oncologists welcome it.

A second opinion is especially useful when:

  • The cancer is rare or advanced
  • Surgery is complex
  • Fertility preservation is being considered
  • You have been offered very different treatment options

Bring these to your second-opinion appointment:

  • Pathology report and biopsy slides or blocks
  • Scan images (CD/DVD or link) and reports
  • Blood test results, including tumor markers
  • Summary of any treatment received so far

2. Survival Rates, Staging and Prognosis

What is the survival rate for gynecological cancer?

Five-year survival rates for gynecological cancer range from over 90% for many early-stage cancers to below 30% for cancers that have spread to distant organs, which is why stage at diagnosis matters so much.

  • The figures below are approximate U.S. population data (SEER).
  • They describe large groups of women treated in past years, not any one person.
  • Newer treatments mean outcomes for women diagnosed today may be better than these figures suggest.

Table 4. Approximate five-year relative survival by stage

Cancer TypeLocalized (confined to organ)Regional (nearby spread)Distant (spread far)All Stages
Uterine / Endometrial~95%~70%~18–19%~81%
Cervical~91%~60%~19%~67%
Ovarian~92%~73%~31%~51%
Vulvar~86%~51%~20%~70%
Vaginal~69%~57%~26%~51%

Source: rounded approximations of U.S. SEER five-year relative survival, for general education only. Your oncologist can explain your individual outlook.

What stage is my cancer and what does it mean?

Your cancer stage describes how far the cancer has spread, and it is one of the most important factors in choosing treatment and estimating prognosis.

  • Gynecological cancers are staged using the FIGO system (International Federation of Gynecology and Obstetrics), from Stage I to Stage IV.
  • Each stage has sub-stages (for example IA, IB, IIIC), and definitions differ by cancer type.
  • For endometrial cancer, the 2023 FIGO system also includes molecular features such as POLE mutation or p53 abnormality.

Table 5. FIGO stages explained

StageGeneral MeaningTypical Treatment Approach
Stage ICancer is confined to the organ where it startedSurgery alone or with limited additional treatment; cure rates are high
Stage IISpread to nearby pelvic structures (e.g. cervix, pelvic tissues, upper vagina)Surgery and/or radiation, often with chemotherapy
Stage IIISpread to lymph nodes, the abdominal lining or further within the pelvisCombination of surgery, chemotherapy and/or radiation, plus maintenance therapy where appropriate
Stage IVSpread to the bladder, bowel lining or distant organs such as the liver or lungsSystemic therapy (chemotherapy, targeted therapy, immunotherapy), with surgery or radiation in selected cases

Can stage 3 or stage 4 gynecological cancer be treated successfully?

Advanced gynecological cancer is treatable: many women with stage 3 or stage 4 disease achieve remission, and some live for many years with good quality of life.

  • Advanced ovarian cancer: complete removal of visible tumor, chemotherapy and maintenance PARP inhibitors have extended survival, especially for BRCA-mutated or HRD-positive tumors.
  • Locally advanced cervical cancer: chemoradiation with brachytherapy cures a substantial proportion of women; immunotherapy benefits selected high-risk patients.
  • Advanced endometrial cancer: adding immunotherapy to chemotherapy has improved outcomes, particularly for mismatch repair-deficient (dMMR) tumors.
  • Palliative and supportive care, offered alongside active treatment, helps control symptoms at every stage.

What does the grade of my tumor mean?

Tumor grade describes how abnormal the cancer cells look under the microscope and indicates how quickly the cancer is likely to grow and spread.

Table 6. Tumor grade explained

GradeWhat It Means
Low grade (Grade 1)Cells look close to normal and usually grow slowly
Intermediate (Grade 2)Cells are moderately abnormal
High grade (Grade 3)Cells look very abnormal and tend to grow faster; usually treated more intensively
  • Some cancers are simply called “low-grade” or “high-grade” (for example, serous ovarian cancer).
  • High grade does not mean untreatable; many high-grade cancers respond well to chemotherapy.

What factors affect my prognosis?

Prognosis is shaped by the stage, type, grade and molecular profile of your cancer, how completely it can be treated, and your overall health.

  • Stage at diagnosis – one of the strongest factors.
  • Histological type – low-grade endometrioid cancers generally have a better outlook than serous or clear cell cancers.
  • Molecular features – BRCA/HRD, mismatch repair, POLE, p53 and HER2 status.
  • Completeness of surgery – in ovarian cancer, no visible residual disease is strongly linked with longer survival.
  • Response to chemotherapy – especially sensitivity to platinum-based drugs.
  • Age, fitness and other conditions – these influence which treatments are suitable.
  • Specialist care – treatment at a gynecologic oncology center is associated with better surgical outcomes.

3. Symptoms and Warning Signs of Gynecological Cancer

What are the early warning signs of gynecological cancer?

Common warning signs of gynecological cancer include abnormal vaginal bleeding, persistent bloating, pelvic or abdominal pain and changes in the vulvar skin; symptoms lasting more than two weeks should be checked by a doctor.

Table 7. Common symptoms by cancer type

Cancer TypeCommon Symptoms
Uterine / EndometrialBleeding after menopause, bleeding between periods, heavier or prolonged periods, watery or blood-stained discharge, pelvic pain
OvarianPersistent bloating, abdominal swelling, feeling full quickly, loss of appetite, pelvic or abdominal pain, frequent or urgent urination, bowel changes, fatigue, unexplained weight loss
CervicalBleeding after sex, bleeding between periods or after menopause, unusual discharge, pelvic pain (early cervical cancer often has no symptoms)
VulvarPersistent itching, burning or pain, a lump, ulcer or wart-like growth, thickened or discolored skin
VaginalAbnormal bleeding or discharge, a lump in the vagina, pain during sex, painful urination

These symptoms are more often caused by non-cancerous conditions, but they should still be assessed.

Is bleeding after menopause always a sign of cancer?

No, but bleeding after menopause is not considered normal and should be evaluated promptly, because it is the most common symptom of endometrial cancer.

  • About 9 in 10 women with endometrial cancer have abnormal bleeding.
  • Roughly 1 in 10 women with postmenopausal bleeding are found to have endometrial cancer.
  • Most other cases have benign causes: thin vaginal lining (atrophy), polyps or hormone therapy.
  • A transvaginal ultrasound and, if needed, an endometrial biopsy usually identify the cause quickly.

Why is ovarian cancer called a “silent killer”?

Ovarian cancer is often called a “silent killer” because its early symptoms are vague and easily mistaken for digestive problems, so many cases are diagnosed after the cancer has spread.

Ovarian cancer is rarely completely silent. Watch for symptoms that are new, persistent and frequent (most days, for more than 2–3 weeks):

  • Bloating that does not come and go
  • Eating less and feeling full quickly
  • Abdominal or pelvic pain
  • Toilet changes – urinating more often or bowel changes

Next step: If these symptoms persist, ask your doctor about a pelvic examination, a transvaginal ultrasound and a CA-125 blood test.

When should I see a doctor urgently about gynecological symptoms?

See a doctor promptly for unexplained bleeding after menopause, bleeding after sex or symptoms lasting more than two weeks, and seek emergency care for heavy bleeding or severe pain.

Table 8. How urgently to seek care

SymptomAction
Heavy vaginal bleeding soaking a pad every hour for 2 hours or moreGo to emergency care
Severe or sudden abdominal or pelvic painGo to emergency care
Rapidly increasing abdominal swelling or difficulty breathingGo to emergency care
Unable to pass urine or stool, or persistent vomitingSeek same-day medical care
Bleeding after menopause or after sexBook a doctor's appointment within days
New vulvar lump or sore that does not heal within 2 weeksBook a doctor's appointment
Bloating or pelvic discomfort on most days for more than 2–3 weeksBook a doctor's appointment

4. Diagnosis, Tests and Biomarker Testing

What tests will I need to confirm and stage my gynecological cancer?

Gynecological cancer is confirmed by examining tissue under the microscope, and a combination of examination, imaging and blood tests is used to determine the stage.

Table 9. Diagnostic and staging tests

TestPurpose
Pelvic and physical examinationAssesses the size and spread of any visible or palpable tumor
Transvaginal ultrasoundMeasures endometrial thickness and examines the ovaries and uterus
Pap smear, HPV test and colposcopyDetects abnormal cervical cells and guides cervical biopsy
Endometrial biopsy, hysteroscopy or D&CTakes a tissue sample from the lining of the uterus
Tumor markers (CA-125, HE4, CEA, CA 19-9)Supports diagnosis and tracks response to treatment
MRI of the pelvisShows local spread in cervical, endometrial and vulvar cancer
CT scan of chest, abdomen and pelvisChecks for spread to lymph nodes, abdomen, liver and lungs
PET-CT scanDetects spread to lymph nodes and distant sites
Image-guided or laparoscopic biopsyObtains tissue when the tumor is hard to reach
Molecular and genetic testingIdentifies features that guide targeted therapy and immunotherapy

Is a biopsy necessary, and is it painful?

A biopsy, or tissue from surgery, is the standard way to confirm cancer, and most gynecological biopsies cause only mild, short-lived discomfort, although experiences vary.

  • Clinic biopsies (endometrial or cervical) usually take a few minutes and may feel like strong period cramps.
  • Pain relief or local anesthetic can be offered.
  • Hysteroscopy, laparoscopy or image-guided biopsy may be done under sedation or anesthesia.
  • What the biopsy reveals: the exact cancer type, grade and molecular features that guide treatment.

What is CA-125 and should I worry about my CA-125 level?

CA-125 is a blood tumor marker that is raised in most women with advanced ovarian cancer, but a single CA-125 result cannot diagnose or rule out cancer on its own.

  • A commonly used upper limit of normal is 35 U/mL, though laboratories vary.
  • CA-125 can rise with benign conditions: endometriosis, fibroids, pelvic infection, menstruation, pregnancy, liver disease and fluid in the abdomen or chest.
  • About half of early-stage ovarian cancers have a normal CA-125.
  • It is most useful for tracking response to treatment and during follow-up.
  • It may be combined with HE4 (ROMA score) and ultrasound findings to assess a pelvic mass.

Why do I need a PET-CT or MRI scan?

MRI and PET-CT scans show where the cancer is and whether it has spread, which is essential for accurate staging and treatment planning.

Table 10. Imaging scans compared

ScanWhat It Shows BestCommonly Used ForTypical Duration
MRI pelvisDetailed soft-tissue anatomy of the pelvisLocal spread of cervical, endometrial and vulvar cancer30–45 minutes
CT chest, abdomen and pelvisLymph nodes, abdominal spread, liver and lungsStaging ovarian and endometrial cancer10–15 minutes
PET-CTMetabolically active cancer throughout the bodyCervical cancer nodes, radiation planning, suspected recurrenceAbout 2 hours including preparation
  • Not every patient needs every scan.
  • Your oncologist will choose the scans that will change treatment decisions.

What is biomarker or molecular testing, and why does it matter for my treatment?

Biomarker testing analyses the genetic and molecular features of your tumor to identify which targeted therapies and immunotherapies are more likely to help you.

Table 11. Key biomarkers in gynecological cancer

BiomarkerCancer TypeWhy It Matters
BRCA1 / BRCA2 mutationOvarianPredicts benefit from PARP inhibitors; also relevant to family members
HRD (homologous recombination deficiency)OvarianIdentifies BRCA-negative tumors that may also benefit from PARP inhibitors
Mismatch repair (MMR) / MSI statusEndometrial, ovariandMMR/MSI-high tumors often respond to immunotherapy; may indicate Lynch syndrome
POLE mutation and p53 statusEndometrialPOLE-mutated tumors have a very favourable prognosis; p53-abnormal tumors usually need more intensive treatment
PD-L1CervicalHelps select patients for immunotherapy
HER2Endometrial (serous), othersAllows HER2-targeted therapy
Folate receptor alpha (FRα)OvarianIdentifies eligibility for antibody-drug conjugate therapy

How long does it take to get my biopsy and test results?

Most biopsy results are available within about 3 to 7 working days, while specialised molecular and genetic tests usually take 2 to 4 weeks.

Table 12. Typical test result turnaround times

TestTypical Turnaround*Can Treatment Start Before Results?
Blood tests and tumor markersSame day to 2 daysNot applicable
CT / MRI reportSame day to 2 daysNot applicable
PET-CT report1–2 daysNot applicable
Biopsy (histopathology)3–7 working daysNo – diagnosis must be confirmed first
Immunohistochemistry (IHC), MMR, p53Adds 2–5 working daysSometimes
Tumor genomic tests (BRCA, HRD, POLE)2–4 weeksOften yes – plan adjusted when results arrive
Germline (inherited) genetic testing2–4 weeksOften yes

*Turnaround times vary between laboratories.

5. Gynecological Cancer Treatment Options

What is the best treatment for my gynecological cancer?

The most suitable treatment depends on the type, stage, grade and molecular profile of your cancer, and it is decided by a multidisciplinary tumor board to fit your individual needs.

Table 13. Main treatments by cancer type and stage

Cancer TypeEarly StageAdvanced Stage
Uterine / EndometrialHysterectomy with removal of tubes and ovaries, plus sentinel lymph node mapping; radiation or brachytherapy if risk features are presentSurgery, chemotherapy plus immunotherapy, radiation, hormone therapy and targeted therapy
OvarianComprehensive staging surgery; chemotherapy for most stages beyond low-grade IA/IBCytoreductive (debulking) surgery and carboplatin–paclitaxel chemotherapy, followed by maintenance PARP inhibitor and/or bevacizumab
CervicalCone biopsy, trachelectomy or radical hysterectomy with lymph node assessmentConcurrent chemoradiation with brachytherapy, with immunotherapy in selected cases
VulvarWide local excision with sentinel lymph node biopsyChemoradiation, with surgery in selected cases
VaginalSurgery or radiationChemoradiation with brachytherapy

Will I need surgery for gynecological cancer, and what type?

Most women with gynecological cancer have surgery, which is often central to both staging and treating the disease.

Table 14. Types of gynecological cancer surgery

ProcedureWhat Is Removed or DoneCommonly Used For
Total hysterectomy with bilateral salpingo-oophorectomyUterus, cervix, fallopian tubes and ovariesEndometrial and ovarian cancer
Radical hysterectomyUterus, cervix, upper vagina and surrounding tissues (parametrium)Early cervical cancer
Radical trachelectomyCervix and surrounding tissue, preserving the uterusSmall early cervical cancer in women wishing to have children
Sentinel lymph node biopsyOnly the first draining lymph nodes, identified with a tracer dyeEndometrial, cervical and vulvar cancer
Cytoreductive (debulking) surgeryAll visible tumor, sometimes including bowel, omentum or spleenAdvanced ovarian cancer
Wide local excision / radical vulvectomyTumor with a margin of healthy tissueVulvar cancer

Table 15. Typical hospital stay and recovery after surgery

SurgeryHospital Stay*Light ActivityReturn to Desk Work*Driving*
Robotic / laparoscopic hysterectomy1 night (0–2)Within days2–4 weeksAbout 2 weeks
Open (abdominal) hysterectomy3–5 days1–2 weeks6–8 weeks4–6 weeks
Radical hysterectomy / trachelectomy2–5 days1–2 weeks4–8 weeks3–6 weeks
Cytoreductive (debulking) surgery5–10 days2–3 weeks6–12 weeks4–6 weeks
Vulvar surgery1–5 days1–2 weeks3–8 weeks2–6 weeks

*Recovery varies with the extent of surgery, your fitness and any complications. Drive only when you can perform an emergency stop comfortably and are not taking sedating pain medication.

Is robotic or laparoscopic surgery an option for my gynecological cancer?

Robotic and laparoscopic (keyhole) surgery is the preferred approach for most early-stage endometrial cancers and many other gynecological procedures, offering faster recovery with comparable cancer outcomes in large studies.

Potential benefits:

  • Smaller incisions, less pain and less blood loss
  • Shorter hospital stay, often one night
  • Faster return to normal activities, typically within two to four weeks
  • Lower risk of wound infection and hernia

Important: For early cervical cancer requiring radical hysterectomy, a major international trial (LACC) found higher recurrence rates with minimally invasive surgery, so open surgery is generally recommended for most patients. Advanced ovarian cancer also usually requires open surgery. Your surgeon will recommend the safest approach for your cancer.

What is debulking surgery for ovarian cancer?

Debulking (cytoreductive) surgery removes as much ovarian cancer as possible, ideally leaving no visible tumor, which is one of the strongest predictors of long-term survival.

  • Primary debulking: surgery as the first treatment.
  • Interval debulking: surgery after 3–4 cycles of chemotherapy have shrunk the tumor.
  • The choice depends on: extent of disease, your fitness and whether complete removal is achievable.
  • Who should perform it: an experienced gynecologic oncologist, as this is complex surgery.

Will I need chemotherapy, and how many cycles?

Chemotherapy is a standard part of treatment for most ovarian cancers and for many advanced cervical and endometrial cancers, commonly given as six cycles over about four to five months.

Table 16. Common systemic treatment schedules at a glance

TreatmentCancer TypeHow OftenTypical CourseSetting / Time per Visit
Carboplatin + paclitaxelOvarian, endometrialEvery 3 weeks6 cycles (about 18 weeks)Day care; about 4–6 hours
Weekly cisplatin with radiationCervical, vulvar, vaginalWeekly5–6 doses over 5–6 weeksDay care; about 3–4 hours with hydration
PARP inhibitor (olaparib, niraparib)Ovarian (maintenance)Daily tabletsUp to 2–3 years, depending on drugAt home; monthly review and blood tests
BevacizumabOvarian, cervicalEvery 3 weeksOften about 12–15 months in totalDay care; about 30–90 minutes
Immunotherapy (pembrolizumab, dostarlimab)Endometrial, cervicalEvery 3–6 weeksUp to about 2–3 yearsDay care; about 30–60 minutes

Schedules are typical examples. Your regimen may differ based on your cancer, blood counts and tolerance.

What is radiation therapy and brachytherapy for gynecological cancer?

Radiation therapy uses precisely targeted high-energy beams to destroy cancer cells and is a curative treatment for many cervical, vaginal and vulvar cancers.

Table 17. Radiation treatment types and schedules

TypeHow It WorksUsed ForTypical Schedule
External beam radiation (IMRT / VMAT / IGRT)Shaped beams from a machine that spare the bladder and bowelCervical, vulvar, vaginal and high-risk endometrial cancer25–28 daily sessions, 5 days a week, over 5–6 weeks; about 15–20 minutes each
Brachytherapy for cervical cancerRadiation source placed temporarily inside the uterus and vaginaCervical cancer (a key part of curative treatment)Usually 3–5 sessions, after or during external beam
Vaginal cuff brachytherapyCylinder placed in the vagina to treat its upper portionAfter endometrial cancer surgery2–6 outpatient sessions over 1–3 weeks; about 30 minutes each
Stereotactic radiation (SBRT)Very precise, high-dose treatmentLimited recurrences or metastases1–5 sessions

Timing matters: For locally advanced cervical cancer, completing chemoradiation and brachytherapy within about eight weeks is associated with the best chance of cure.

What are targeted therapies such as PARP inhibitors, and will they work for me?

Targeted therapies attack specific molecular weaknesses in cancer cells, and PARP inhibitors are among the most significant recent advances in ovarian cancer treatment.

  • PARP inhibitors (olaparib, niraparib, rucaparib): tablets taken after chemotherapy as maintenance; greatest benefit in BRCA-mutated and HRD-positive ovarian cancer.
  • Bevacizumab: blocks tumor blood vessel growth; used in ovarian and cervical cancer.
  • Mirvetuximab soravtansine: antibody-drug conjugate for platinum-resistant ovarian cancer with high folate receptor alpha.
  • Tisotumab vedotin: antibody-drug conjugate for recurrent or metastatic cervical cancer.
  • Trastuzumab and trastuzumab deruxtecan: for HER2-positive tumors, including some serous endometrial cancers.
  • Lenvatinib with pembrolizumab: for advanced endometrial cancer after prior chemotherapy.

Availability and regulatory approvals vary by country. Your oncologist will recommend targeted therapy based on your biomarker results.

Is immunotherapy effective for gynecological cancer?

For many advanced endometrial and cervical cancers, immunotherapy is now a standard treatment option and can produce long-lasting responses in some women.

  • Endometrial cancer: checkpoint inhibitors (dostarlimab or pembrolizumab) with chemotherapy improve survival in advanced or recurrent disease; largest benefit in dMMR/MSI-high tumors.
  • Cervical cancer: pembrolizumab with chemotherapy improves survival in PD-L1-positive recurrent or metastatic disease, and with chemoradiation benefits selected high-risk locally advanced cancers.
  • Ovarian cancer: benefit has been limited so far; mainly offered through clinical trials.
  • Side effects: can affect the thyroid, skin, bowel, lungs or liver – report new symptoms promptly.

What is HIPEC, and am I a candidate?

HIPEC (hyperthermic intraperitoneal chemotherapy) is heated chemotherapy circulated through the abdomen during surgery, and it may improve survival for carefully selected women with advanced ovarian cancer.

  • Evidence: in a major randomised trial, adding HIPEC to interval debulking for stage III ovarian cancer extended average survival by about a year.
  • Who may be eligible: women who received chemotherapy before surgery and are fit for extended surgery.
  • Where it is offered: specialised centers with HIPEC expertise.
  • Next step: ask your surgical oncologist whether you are a suitable candidate.

What is a tumor board, and who will be on my cancer care team?

A tumor board is a meeting where specialists from each relevant field review your case together to agree on a recommended treatment plan.

  • Gynecologic oncologist (specialist cancer surgeon)
  • Medical oncologist (chemotherapy, targeted therapy and immunotherapy)
  • Radiation oncologist
  • Pathologist and radiologist
  • Genetic counselor and fertility specialist
  • Oncology nurse navigator, dietitian, physiotherapist, psycho-oncologist and palliative care team

Can I join a clinical trial for gynecological cancer?

Clinical trials offer access to promising new treatments and may be a suitable option for women at many stages of gynecological cancer.

  • Trials are carefully regulated and ethically reviewed.
  • Participants generally receive at least the current standard of care.
  • You can withdraw at any time.
  • Ask whether any trials match your cancer type, stage and biomarkers, especially if your cancer is rare, advanced or has returned.

6. Side Effects and Managing Treatment

What side effects should I expect from gynecological cancer treatment?

Side effects depend on the treatment you receive; many are temporary, and most can be reduced with modern supportive care.

Table 18. Common side effects and how they are managed

TreatmentCommon Side EffectsHow They Are Managed
SurgeryPain, tiredness, wound healing issues, blood clots, bladder or bowel changes, lymphedema, surgical menopauseEnhanced recovery (ERAS) protocols, early mobilisation, blood thinners, physiotherapy
ChemotherapyFatigue, nausea, hair loss, low blood counts and infection risk, numbness or tingling (neuropathy), mouth soresAnti-nausea medicines, growth factor injections, dose adjustments, regular blood tests
Pelvic radiationDiarrhea, bladder irritation, skin soreness, fatigue, vaginal dryness and narrowingDietary changes, medications, vaginal dilators, skin care
PARP inhibitorsAnemia, low platelets, nausea, fatigueRegular blood counts, dose reduction or short breaks
BevacizumabHigh blood pressure, protein in urine, delayed wound healingBlood pressure and urine monitoring
ImmunotherapyThyroid problems, skin rash, diarrhea or colitis, inflammation of lungs or liverEarly reporting, steroids or hormone replacement as needed

Will I lose my hair during chemotherapy?

Most women who receive carboplatin and paclitaxel, a standard chemotherapy for ovarian and endometrial cancer, lose their hair, and in most women it grows back after treatment.

Table 19. Typical hair loss and regrowth timeline

StageTypical Timing*
Hair thinning begins2–3 weeks after the first cycle
Most hair lostBy the second or third cycle
Regrowth beginsUsually within 1–3 months after the last cycle
Reasonable coverageAround 3–6 months after finishing
Texture or colour changesMay occur temporarily with new growth
  • Weekly cisplatin with radiation rarely causes significant hair loss.
  • Scalp cooling may reduce hair loss for some patients.
  • Wigs, scarves and head wraps can help you feel more comfortable.

*Timelines vary between individuals.

How can I manage fatigue, nausea and neuropathy during treatment?

Fatigue, nausea and neuropathy are common treatment side effects, and each can often be reduced with a combination of medication and self-care.

  • Fatigue: research shows gentle daily exercise such as walking can reduce cancer-related fatigue; balance activity with rest and ask about anemia or thyroid checks.
  • Nausea: take anti-nausea medicines as prescribed before symptoms start; eat small, frequent, bland meals and stay hydrated.
  • Neuropathy: report tingling or numbness early so your dose can be adjusted; protect your feet and take care on stairs.
  • Appetite and weight: a cancer dietitian can help you maintain strength and muscle mass.

What is lymphedema, and can it be prevented?

Lymphedema is swelling of the legs or genital area caused by damage to lymph nodes from surgery or radiation, and its risk can be reduced with sentinel lymph node techniques and early care.

  • Sentinel node mapping removes fewer nodes than full lymphadenectomy, lowering the risk.
  • Watch for heaviness, tightness or swelling in one or both legs.
  • Early specialist physiotherapy, compression garments, skin care and exercise tend to give the best results.
  • Protect affected limbs from cuts and insect bites; treat skin infections promptly.

When should I call my oncology team immediately?

Contact your oncology team immediately, day or night, if you develop a temperature of 38°C (100.4°F) or above during chemotherapy, as this may signal a serious infection.

Table 20. When to contact your care team

SymptomThresholdAction
Fever or chills38.0°C (100.4°F) or above, or shiveringCall immediately / go to emergency
Breathlessness or chest painAny new or sudden onsetGo to emergency care
Vaginal bleedingSoaking a pad every hourGo to emergency care
DiarrheaMore than 4–6 episodes a day above your normal, or lasting over 24 hoursCall the same day
VomitingUnable to keep fluids down for 12–24 hoursCall the same day
Leg pain or swellingOne leg red, painful or swollenCall the same day (possible blood clot)
Confusion or severe headacheAny new episodeGo to emergency care

Follow any specific thresholds your own team gives you. +91 88840 09955

7. Fertility, Menopause and Sexual Health

Can I still have children after gynecological cancer?

For selected women with early-stage gynecological cancer, fertility-sparing treatment is possible, so discuss fertility with your oncologist before treatment begins.

Table 21. Fertility-sparing options

Cancer TypeFertility-Sparing OptionWho May Be Eligible
Cervical cancerCone biopsy or radical trachelectomy (removing the cervix while keeping the uterus)Small, early-stage tumors (generally stage IA to IB1, 2 cm or less)
Endometrial cancerHormonal (progestin) therapy, often with a hormone-releasing IUD, and close monitoringLow-grade (grade 1) endometrioid cancer confined to the uterine lining
Ovarian cancerRemoval of only the affected ovary and tube, preserving the uterus and other ovarySelected early-stage epithelial tumors, borderline tumors and germ cell tumors
Any cancer needing pelvic radiation or chemotherapyEgg, embryo or ovarian tissue freezing; moving the ovaries out of the radiation field (ovarian transposition)Women wishing to preserve fertility who can safely delay treatment briefly
  • Egg or embryo freezing usually takes about 2–3 weeks.
  • After fertility-sparing treatment, many women are advised to consider definitive surgery once their family is complete.

Will cancer treatment cause early menopause?

Removing both ovaries or giving pelvic radiation causes menopause in premenopausal women, and some chemotherapy can also stop ovarian function.

Possible symptoms:

  • Hot flashes and night sweats
  • Vaginal dryness
  • Sleep problems and mood changes
  • Longer-term bone thinning and increased heart disease risk

Treatment options:

  • Hormone replacement therapy (HRT) may be an option for many women after cervical cancer and after most epithelial ovarian cancers, following individual assessment.
  • HRT may not be suitable after hormone-sensitive cancers such as low-grade serous ovarian cancer, granulosa cell tumors and some endometrial cancers.
  • Non-hormonal options: certain medicines, vaginal moisturisers, bone health monitoring and lifestyle measures.

Can I have sex during and after gynecological cancer treatment?

Many women resume a satisfying sex life after gynecological cancer treatment, although some adjustments and support may be needed.

  • Wait until your team confirms healing, typically about six to eight weeks after hysterectomy.
  • Use reliable contraception during chemotherapy and radiation if pregnancy is possible.
  • Water- or silicone-based lubricants and vaginal moisturisers ease dryness.
  • Vaginal dilators after pelvic radiation or brachytherapy help reduce narrowing.
  • Pelvic floor physiotherapy and sexual health counselling can help with pain, low desire and body image.
  • Cancer itself cannot be passed to a partner through sex (HPV, which causes some gynecological cancers, can be transmitted).

8. Genetics and Hereditary Cancer Risk (BRCA and Lynch Syndrome)

Is gynecological cancer hereditary?

Some gynecological cancers are hereditary: up to about one in five ovarian cancers and around 3–5% of endometrial cancers are linked to an inherited gene mutation.

Table 22. Inherited conditions and gynecological cancer risk

Inherited ConditionAssociated CancersApproximate Lifetime Risk
BRCA1 mutationOvarian, fallopian tube, breastOvarian cancer: roughly 39–44%
BRCA2 mutationOvarian, breast, pancreatic, prostateOvarian cancer: roughly 11–17%
Lynch syndrome (MLH1, MSH2, MSH6, PMS2)Endometrial, ovarian, colorectalEndometrial cancer: up to about 40–60% depending on the gene
Other genes (RAD51C, RAD51D, BRIP1, PALB2)Ovarian, breastModerately increased ovarian cancer risk
  • International guidelines recommend genetic testing for all women with epithelial ovarian, fallopian tube or primary peritoneal cancer, regardless of family history.
  • Tumor mismatch repair testing is recommended for all endometrial cancers.

Does a BRCA mutation change my cancer treatment?

A BRCA mutation is associated with a higher likelihood of response to platinum chemotherapy and PARP inhibitor maintenance, which can keep ovarian cancer in remission for longer.

Your genetic results may also influence:

  • Surgical planning
  • Screening for other cancers, such as breast cancer
  • Decisions about risk-reducing surgery
  • Testing recommendations for your relatives

Should my family members get genetic testing?

If you carry an inherited mutation, each of your parents, siblings and children has a 50% chance of carrying it, and knowing this can help them take preventive steps.

  • Genetic counselling helps relatives understand their risks and testing options (cascade testing).
  • BRCA1 carriers are generally advised to consider risk-reducing removal of the tubes and ovaries between ages 35 and 40, and BRCA2 carriers between 40 and 45, once childbearing is complete.
  • Women with Lynch syndrome may consider risk-reducing hysterectomy and removal of the ovaries after completing their family, and need regular colonoscopy.
  • Male relatives can also carry and pass on these mutations.

9. Screening, Early Detection and Prevention

Can gynecological cancer be prevented?

Cervical cancer is one of the most preventable cancers, and the risk of several other gynecological cancers can be substantially reduced.

  • HPV vaccination helps prevent the infections that cause most cervical, vaginal and vulvar cancers.
  • Regular cervical screening finds and treats precancerous changes early.
  • Maintaining a healthy weight lowers endometrial cancer risk.
  • Oral contraceptive use for several years is associated with lower ovarian and endometrial cancer risk.
  • Not smoking reduces the risk of cervical, vulvar and vaginal cancer.
  • Genetic testing and risk-reducing surgery for women with BRCA mutations or Lynch syndrome.
  • Opportunistic salpingectomy during other pelvic surgery may lower ovarian cancer risk.

How often should I have a Pap smear or HPV test?

Most women aged 25 or 30 to 65 are advised to have cervical screening every five years with an HPV test, or every three years with a Pap smear alone.

Table 23. Cervical screening intervals by age

Age GroupRecommended Screening (typical international guidance)
Under 21–25Routine screening is not recommended
21/25 to 29Pap smear every 3 years, or primary HPV test every 5 years from age 25 where available
30 to 65Primary HPV test every 5 years (preferred), co-testing (HPV + Pap) every 5 years, or Pap alone every 3 years
Over 65Screening may stop after consistently normal results in the previous 10 years
After hysterectomy for benign reasonsUsually not needed if the cervix was removed and there was no history of precancer

Recommendations differ between countries. The World Health Organization recommends HPV-based screening from age 30. Follow your doctor's advice and local guidelines.

Is there a screening test for ovarian cancer?

There is currently no proven screening test for ovarian cancer in women at average risk, which is why knowing the symptoms is so important.

  • Large trials of routine CA-125 and ultrasound have not shown a reduction in ovarian cancer deaths.
  • For women at high genetic risk, risk-reducing surgery is the most effective protection.
  • Surveillance may be offered to high-risk women until surgery is appropriate.

Does the HPV vaccine really prevent cervical cancer, and who should get it?

The HPV vaccine is highly effective and, when given before exposure to HPV, can prevent the large majority of cervical cancers.

Table 24. HPV vaccination by age

AgeRecommendation
9–14 years (girls and boys)Ideal age; before sexual activity begins
15–26 yearsCatch-up vaccination recommended in many countries
27–45 yearsMay benefit some adults; discuss with your doctor
  • Vaccinated women still need regular cervical screening.
  • The vaccine has a strong safety record; common side effects are a sore arm or mild fever.

10. Life After Treatment: Follow-Up and Recurrence

What are the chances my gynecological cancer will come back?

Recurrence risk depends on the type and stage of your cancer: it is low for many early-stage endometrial and cervical cancers and higher for advanced ovarian cancer.

  • Early-stage endometrial cancer: most women do not experience a recurrence.
  • Cervical cancer: most recurrences, if they occur, happen within the first two to three years.
  • Advanced ovarian cancer: around 70% of women experience a recurrence, which is why maintenance therapy and follow-up are important; recurrent ovarian cancer can often be treated, sometimes for many years.

What will my follow-up care look like after treatment?

Follow-up care involves regular check-ups with your oncology team, most frequently in the first two to three years after treatment when recurrence risk is highest.

Table 25. Typical follow-up schedule after treatment

Time Since TreatmentTypical Visit FrequencyWhat Is Checked
Years 1–2Every 3–4 monthsSymptoms, physical and pelvic examination, CA-125 or other markers where relevant, side effect management
Years 3–5Every 6 monthsExamination, tests as indicated, bone and heart health, sexual and emotional wellbeing
After 5 yearsOnce a yearLong-term survivorship care, screening for other cancers, healthy lifestyle support
  • Routine scans are not always needed if you feel well.
  • Imaging is usually arranged when symptoms or test results suggest a problem.
  • Report new or persistent symptoms between visits.

What happens if my cancer comes back?

Recurrent gynecological cancer can often still be treated, and many women live for years with good quality of life after a recurrence.

  • Ovarian cancer returning six months or more after platinum chemotherapy (platinum-sensitive) often responds to platinum again; selected women benefit from secondary surgery.
  • Localised recurrences of endometrial, cervical or vulvar cancer may be curable with surgery or radiation.
  • Newer options include targeted therapy, immunotherapy, antibody-drug conjugates, hormone therapy and clinical trials.
  • Palliative care helps control pain and other symptoms alongside active treatment.

What should I eat, and how much should I exercise after gynecological cancer?

A balanced, mainly plant-based diet and regular physical activity support energy, strength and quality of life after gynecological cancer, and may lower recurrence risk for some cancers.

  • At least 150 minutes of moderate activity a week, plus muscle-strengthening exercise twice a week.
  • Mostly vegetables, fruit, whole grains and legumes, with adequate lean protein.
  • Limit processed and red meat, sugary drinks and highly processed foods.
  • Reach and maintain a healthy weight, particularly after endometrial cancer.
  • Avoid or minimise alcohol, and do not smoke.
  • Check with your team before taking herbal remedies or supplements.

11. Emotional Support, Practical Concerns and Next Steps

How do I cope emotionally with a gynecological cancer diagnosis?

Feeling shocked, frightened, angry or low after a cancer diagnosis is common and understandable, and professional emotional support is an important part of cancer care.

  • Talk to a psycho-oncologist, counsellor or psychologist experienced in cancer care.
  • Join a support group of women with gynecological cancer, in person or online.
  • Bring a trusted person to appointments to listen and take notes.
  • Tell your team about persistent low mood, anxiety or poor sleep; these can be treated.
  • Mindfulness, yoga and gentle exercise may help reduce stress.

Can I continue working during gynecological cancer treatment?

Many women continue working during treatment, often with adjusted hours or duties, although most need some time off after surgery.

Table 26. Planning work around treatment

Treatment PhaseTypical Impact on Work*
Keyhole (robotic / laparoscopic) surgery2–4 weeks off
Open surgery6–8 weeks off; longer after debulking surgery
Chemotherapy every 3 weeksOften most tired for 3–7 days after each cycle; many work part-time
Daily radiation (5–6 weeks)Daily appointment of about 30–60 minutes including travel; fatigue builds toward the end
Maintenance tablets or immunotherapyMost women can work normally
  • Discuss flexible arrangements with your employer.
  • Ask your team for medical certificates when needed.

*Individual experiences vary.

How much does gynecological cancer treatment cost, and will insurance cover it?

The cost of gynecological cancer treatment varies widely with the type of treatment, number of cycles or sessions and length of hospital stay, and many health insurance plans cover a large part of it.

  • Personalised cost estimate from our financial counsellors
  • Help with insurance pre-authorisation and cashless claims
  • Guidance on government and charitable support schemes
  • [Add your hospital's insurance partners and financial assistance details here.]

Table 27. Cost estimate overview (to be completed by hospital)

TreatmentEstimated Cost RangeTypically Covered by Insurance?
Robotic / laparoscopic hysterectomy[₹ / $ range][Yes / Partial]
Cytoreductive surgery[range][ ]
Chemotherapy (per cycle)[range][ ]
Radiation therapy (full course)[range][ ]
Targeted therapy / immunotherapy (per month)[range][ ]

What questions should I ask my oncologist at my first appointment?

Preparing a list of questions before your first appointment helps you understand your diagnosis and take an active part in treatment decisions.

  • What type and subtype of gynecological cancer do I have?
  • What is the stage and grade, and what does that mean for me?
  • Has my tumor been tested for biomarkers such as BRCA, HRD, MMR or PD-L1?
  • What treatment do you recommend, and what are the alternatives?
  • What is the goal of treatment: cure, control or symptom relief?
  • What side effects should I expect, and how will they be managed?
  • Can my fertility be preserved, and will I go into menopause?
  • Should I or my family have genetic testing?
  • Am I eligible for any clinical trials?
  • How long will treatment take, and how will it affect my daily life and work?
  • Who do I contact with questions or in an emergency?
  • What is the likely cost, and what support is available?

Table 28. What to bring to your first appointment

ItemWhy It Helps
Referral letter and prior consultation notesGives the team your full history
Pathology reports and biopsy slides / blocksAllows review of the diagnosis
Scan CDs and reports (ultrasound, CT, MRI, PET-CT)Avoids unnecessary repeat scans
Blood test results, including tumor markersProvides a baseline
List of current medicines and allergiesEnsures treatment is safe
Insurance card and IDSpeeds up registration and pre-authorisation
A family member or friendHelps with listening, notes and support

Why Choose Our Gynecological Cancer Center?

At Aster Whitefield Hospital, women with gynecological cancer receive care from a dedicated multidisciplinary team at every step:

  • Dedicated gynecologic oncology tumor board reviewing every case
  • Robotic and minimally invasive cancer surgery
  • Fertility preservation and onco-fertility counselling
  • Genetic counselling and BRCA/Lynch syndrome testing
  • Advanced radiation therapy and image-guided brachytherapy
  • Access to targeted therapy, immunotherapy and clinical trials
  • Psycho-oncology, nutrition, physiotherapy and palliative care support

Book a consultation with a gynecologic oncologist. Call +91 88840 09955 or /contact/ to schedule an appointment or request a second opinion.

Medical disclaimer: This information is for general education and does not replace professional medical advice. Survival statistics, timelines and treatment options are general and may not apply to your situation. Always consult your treating oncologist.

Medical review and sources

Medically reviewed by Dr Ashwin K.R. · Last reviewed: 10 October 2026

  • National Comprehensive Cancer Network (NCCN) Guidelines: Cervical Cancer; Ovarian Cancer including Fallopian Tube and Primary Peritoneal Cancers; Uterine Neoplasms
  • European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for gynaecological cancers

Medical disclaimer: This information is for general education and does not replace personalised medical advice. Please consult a qualified doctor about your specific diagnosis and treatment.